You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 2, February 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Sexually Transmitted Diseases
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Amplified DNA Testing for Sexually Transmitted Diseases

New Opportunities and New Questions

Arch Pediatr Adolesc Med. 1999;153:111-113.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

WHILE READING about the various new technologies being introduced into the field of pediatrics, I often find myself thinking, "If only the health problems of adolescents were amenable to such advances." At last, that is about to change. The US Food and Drug Administration has approved the first commercial DNA amplification tests for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections and more approvals will follow soon. Work on a polymerase chain reaction test for the detection of Trichomonas vaginalis is also well advanced. I do not think it hyperbole to say that the availability of these new tests will revolutionize our approach to the detection of sexually transmitted diseases (STDs), a major cause of morbidity among adolescents, especially young women. The widespread availability of such tests could not come at a more auspicious time. Adolescents continue to have very high rates of STDs and current research indicates that . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Is the Routine Pelvic Examination Needed With the Advent of Urine-Based Screening for Sexually Transmitted Diseases?
Mary-Ann B. Shafer, Robert H. Pantell, and Julius Schachter
Arch Pediatr Adolesc Med. 1999;153(2):119-125.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Provider willingness to screen all sexually active adolescents for chlamydia
Boekeloo et al.
Sex. Transm. Infect. 2002;78:369-373.
ABSTRACT | FULL TEXT  

Improving Human Immunodeficiency Virus Testing for Adolescents
Joffe
Arch Pediatr Adolesc Med 2001;155:761-762.
FULL TEXT  

Urine-Based Screening for STDs
JWatch General 1999;1999:8-8.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.